lobbying_activities: 1257896

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1257896	6dc668bf-df49-4fdf-a1fd-fbcccb1db8c3	Q2	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2012	second_quarter	MED	AACC contacted House leaders to support provisions Sections 721 and 203(f) of H.R.5651, Food and Drug Administration Reform Act of 2012, which sought to streamline the FDA de novo medical device review process and give the HHS Secretary authority to waive FDA medical device user fees in the interest of public health.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2012-07-03T10:56:49.673000-04:00